Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fahn

Showing results (41-50 of 407) with videos related to

Pageof 41
Sort By:
The New England Journal of Medicine|August 10, 1978
Post-anoxic action myoclonus: improvement with valproic acidS Fahn
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1987
Systemic therapy of dystoniaS Fahn
Advances in Neurology|January 1, 1986
Newer drugs for posthypoxic action myoclonus: observations from a well-studied caseS Fahn
Journal of Neural Transmission. Supplementum|October 5, 2006
A new look at levodopa based on the ELLDOPA studyS Fahn
The New England Journal of Medicine|November 26, 1992
Fetal-tissue transplants in Parkinson's diseaseS Fahn
Reviews in the Neurosciences|May 13, 2011
What are the Basal Ganglia diseases?S Fahn
Reviews in the Neurosciences|May 13, 2011
Current trends in the treatment of Basal Ganglia diseasesS Fahn
Annals of Neurology|January 1, 1992
A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's diseaseS Fahn
The New England Journal of Medicine|October 9, 1980
Levodopa provocative test for Huntington's diseaseS Fahn
Advances in Neurology|January 1, 1983
High-dosage anticholinergic therapy in dystoniaS Fahn
Pageof 41

Showing results (41-50 of 407) with videos related to

Sort By:
Pageof 41
The New England Journal of Medicine|August 10, 1978
Post-anoxic action myoclonus: improvement with valproic acidS Fahn
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1987
Systemic therapy of dystoniaS Fahn
Advances in Neurology|January 1, 1986
Newer drugs for posthypoxic action myoclonus: observations from a well-studied caseS Fahn
Journal of Neural Transmission. Supplementum|October 5, 2006
A new look at levodopa based on the ELLDOPA studyS Fahn
The New England Journal of Medicine|November 26, 1992
Fetal-tissue transplants in Parkinson's diseaseS Fahn
Reviews in the Neurosciences|May 13, 2011
What are the Basal Ganglia diseases?S Fahn
Reviews in the Neurosciences|May 13, 2011
Current trends in the treatment of Basal Ganglia diseasesS Fahn
Annals of Neurology|January 1, 1992
A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's diseaseS Fahn
The New England Journal of Medicine|October 9, 1980
Levodopa provocative test for Huntington's diseaseS Fahn
Advances in Neurology|January 1, 1983
High-dosage anticholinergic therapy in dystoniaS Fahn
Pageof 41